Drug Target Selection for Trypanosoma cruzi Metabolism by Metabolic Control Analysis and Kinetic Modeling

Area of Science:

• Parasitology
• Systems Biology
• Biochemistry

Background:

• Gene essentiality is commonly used to identify therapeutic targets in trypanosomatid metabolism, but often identifies too many essential genes.
• Additional criteria are needed for effective drug target prioritization in parasitic diseases.
• Metabolic Control Analysis (MCA) and kinetic modeling offer quantitative methods to assess enzyme control over metabolic pathways.

Purpose of the Study:

• To review the principles of MCA and kinetic modeling for identifying crucial enzymes in metabolic pathways.
• To analyze experimental strategies for determining flux control coefficients.
• To demonstrate the application of MCA and kinetic modeling in prioritizing drug targets for trypanosomatid parasites.

Main Methods:

• Utilized Metabolic Control Analysis (MCA) to quantify enzyme control over metabolic flux and intermediate concentrations.
• Employed kinetic modeling of metabolic pathways as a systems biology approach.
• Applied MCA and kinetic modeling to trypanothione metabolism in *Trypanosoma cruzi*.
• Validated model predictions through in vivo experiments.

Main Results:

• MCA identifies that typically two or three enzymes exert the highest control over metabolic pathway flux.
• Inhibition of high-control enzymes has a greater impact on pathway function than low-control enzymes.
• In *Trypanosoma cruzi* antioxidant metabolism, three out of ten enzyme reactions were identified as the most controlling.

Conclusions:

• MCA and kinetic modeling provide a robust framework for prioritizing therapeutic targets in parasite metabolism.
• This approach moves beyond simple gene essentiality to identify enzymes with the greatest impact on parasite survival.
• The findings support the use of MCA and kinetic modeling for drug development against trypanosomatids and other parasites.